Show simple item record

dc.contributor.authorAntonius Padua, Ratu
dc.contributor.authorRatu, Antonius Padua
dc.contributor.authorsimanjuntak, Partomuan
dc.contributor.authorsetyahadi, Siswa
dc.date.accessioned2016-10-26T03:10:25Z
dc.date.available2016-10-26T03:10:25Z
dc.date.issued2016-08-27
dc.identifier.citationSinghal, AK., Naithani, V., Bangar, OP. 2012. Medicinal plants with a potential to treat Alzheimer and associated symptoms. International Journal of Nutrition, Pharmacology, Neurological Diseases. 2(2):84-91. Ferreira, A, Proença, C, Serralheiro, MLM, Araújo, MEM. 2006. The in vitro screening for acetylcholinesterase inhibition and antioxidant activity of medicinal plants from Portugal. Journal of Ethnopharmacology. 108(1):31-37. Williams, P., Sorribas, A., Howes, MJ. 2011. Natural products as a source of Alzheimer‟s drug leads. Nat Prod Rep. 28(1):48–77. Dall‟Acqua, S. 2013. Plant-derived acetylcholinesterase inhibitory alkaloids for the treatment of Alzheimer‟s disease. Botanics: Targets and Therapy..3 :19-28 Mohamed, T., Rao, PPN. 2011. Alzheimer‟s disease: Emerging trends in small molecule therapies. Curr Med Chem. 18(28):4299–4320. Hodges, JR. 2006. Alzheimer‟s centennial legacy: origins, landmarks and the current status of knowledge concerning cognitive aspects. Brain.129: 2811-2822. Orhan, I., Sene,r B., Choudhary, MI., Khalid, A. 2004. Acetylcholinesterase and butyrylcholinesterase inhibitory activity of some Turkish medicinal plants.J. Ethnopharmacol. 91: 57-60. Hung, TM., Ngoc, TM., Youn, UJ., Min ,BS., Na, M., Thuong, PT., Bae, K. 2008. Anti-amnestic activity of pseudocoptisine from Corydalis tuber.Biol. Pharm. Bull. 31: 159-162, Houghton, PJ., Agbedahunsi, JM,, Adegbulugbe, A. 2004. Choline esterase inhibitory properties of alkaloids from two Nigerian Crinum species.Phytochemistry.65: 2893-2896. Rhee,IK., Appels, N., Hofte, B., Karabatak, B., Erkelens, C., Stark, LM., Flippin, LA., Verpoorte, R. 2004. Isolation of the acetylcholinesterase inhibitor ungeremine from Nerine bowdenii by preparative HPLC coupled on-line to a flow assay system. Biol Pharm Bull. 27: 1804-1809. Ahmad, I., Anis, I., Malik, A., Nawas, AS., Choudhary, MI. 2003. Cholinesterase inhibitory constituents from Onosma hispida.Chem Pharm Bull. 51: 412-414. Ferheen, S., Ahmed, E., Afza, N., Malik, A., Shan, MR., Nawas, SA., Choudhary, MI. 2005. Haloxylines A and B, antifungal and cholinesterase inhibiting piperidine alkaloids from Haloxylon salicornicum.Chem Pharm Bull. 53: 570- 572. Ahmad,VU., Khan, A., Farooq, U., Kousar, F., Khan, SS., Nawaz, SA., Abbasi, MA., Choudhary, MI. 2005. Three new cholinesterase-inhibiting cis-clerodane diterpenoids from Otostegia limbata.Chem Pharm Bull. 53: 378-381. Atta-ur-Rahman, Wahab, AT., Nawas,SA., Choudhary, MI. 2004.New cholinesterase inhibiting bisbenzylisoquinoline alkaloids from Cocculus pendulus.Chem Pharm Bull.52: 802-806. Choudhary, MI., Yousuf, S., Nawas,SA., Ahmed, S., Atta-ur-Rahman. 2004 Cholinesterase inhibiting withanolides from Withania somnifera. Chem Pharm Bull. 52: 1358-1361. Sampaio, C.G., Trevisan, M.T.S., Brito, E.S., Santiago, G.M.P, Feitosa, C.M., Carvalho, J.I.X., et.al.2008. Screening for Acetylcholinesterase Inhibitor from Seeds to Treat Alzheimer‟s :4th Brazilian Symposium on Medicinal Chemistry Disease, Division of Medicinal Chemistry, Brazilian Chemical Society (SBQ). BrazMedChem. Owolabi, Moses S., Ogundajo,Akintayo Lanre., Dosoky, Noura S., Setzer William N. 2013. The cytotoxic activity of Annona muricataleaf oil from Badagary, Nigeria. American Journal of Essential Oils and Natural Products. 1 (1): 1-3. Abubacker, M.N., Deepalakshmi, T., 2012. Antioxidant and antibacterial activity of (Annona muricataL.) leaf aqueous extract. International Journal of Plant Science.Vol. 7 ; 301-306. Rachmani , Eka Prasasti Nur., Suhesti, Tuti Sri., Widiastuti, Retno., Aditiyono. 2012. The Breast of Anticancer from Leaf Extract of Annona Muricata Againts Cell Line T47D. International Journal of Applied Science and Technology. Vol. 2 No. 1; 157. George , V Cijo., Kumar, DR Naveen., Rajkumar , V., Suresh, PK., Kumar, R Ashok. 2012.Quantitative Assessment of the Relative Antineoplastic Potential of the n-butanolic Leaf Extract of Annona MuricataLinn. in Normal and Immortalized Human Cell Lines, Asian Pacific Journal of Cancer Prevention. Vol 13. 699 -704 Hamizah, S., Roslida, AH., Fezah, O., Tan, KL., Tor , YS., Tan, CI. 2012. Chemopreventive Potential of Annona MuricataL Leaves on Chemically- Induced Skin Papillomagenesis in Mice. Asian Pacific Journal of Cancer Prevention.Vol 13; 2533-2539. Arthur, FKN., Woode, Eric., Terlabi, EO., Larbie, C. 2012. Bilirubin Lowering Potential of Annona muricata(Linn.) in Temporary Jaundiced Rats. American Journal of Pharmacology and Toxicology. 7 (2): 33-40. Adewole, Stephen O., Martin, Ezekiel A. Caxton. 2006. Morphological Changes and Hypoglycemic Effects of Annona muricataLinn. (Annonaceae) Leaf Aqueous Extract on Pancreatic Β-Cells of Streptozotocin-Treated Diabetic Rats. African Journal of Biomedical Research. Vol. 9; 173 – 187. Kovarik, Z et al. 2013.Acetylcholinesterase active centre and gorge conformations analysed by combinatorial mutations and enantiomeric phosphonates.Biochem. J. 373, 33–40. Ellman GL, Courtney KD, Andres V, Featherstone RM. 1961. Anew and rapid colorimetric determination ofacetylcholinesterase inhibitor activity.Biochem Pharmacol.7: 88-95. Rhee ,In Kyung., van de Meent, Michiel., Ingkaninan, Kornkanok., Verpoorte ,Robert. 2001. Screening for acetylcholinesterase inhibitors from Amaryllidaceaeusing silica gel thin-layer chromatography in combination withbioactivity staining Journal of Chromatography A, 915 :. 217–223 Mehta, M., Adem, A., Sabbagh, Marwan. 2012. New Acetylcholinesterase Inhibitors for Alzheimer‟s Disease. Hindawi Publishing Corporation. International Journal of Alzheimer’s Disease. Volume 2012. Cole GM, Lim GP, Yang F, Teter B, BegumA, Ma Q, Harris-White, ME., Frautschy, SA. 2005. Prevention of Alzheimer's disease:Omega-3 fatty acid and phenolicanti-oxidant interventions. Neurobiol Aging. 05 Dec;26 Suppl 1:133-6.in_ID
dc.identifier.issn2407-9189
dc.identifier.urihttp://hdl.handle.net/11617/7880
dc.description.abstractAlzheimer's disease (AD) is a neurodegenerative disease that is reversible form of dementia. AChE inhibition played a key role not only to enhance cholinergic transmission in the brain but also to reduce the aggregation of Aβ and the formation of neurotoxic fibrils in AD patients. Therefore, inhibition of AChE and BChE has become an outstanding alternative in the treatment of AD. Research on soursop leaf extract aims to determine the activity in the treatment of AD through the activity of AChE inhibition of soursop leaf. AChE inhibitory activity test was carried out based on the method of Ellman et al. (1961). This method is based on the reaction hydrolysis substrate ATCh by AChE that gives the yellow color wavelength of 405 nm. AChE inhibition test results showed that the 96% ethanol extract of the leaves of Annona muricata Linn. has the best inhibitory activity with IC50 of 103.65 mg / L. was quoted extracts ethyl acetate, n-hexane, water direct and indirect water has inhibitory activity of each 339.84 mg / L, 429.36 mg / L, 563.41 mg / L and 598.33 mg / L. Meanwhile, the positive control IC50 value donepezil HCl with IC50 5.29 nM (2.20 µg/L).in_ID
dc.language.isoidin_ID
dc.publisherSTIKES Muhammadiyah Pekajanganin_ID
dc.subjectAcetycholinesterasein_ID
dc.subjectAlzheimerin_ID
dc.subjectAnnona muricata Linnin_ID
dc.subjectEllman methodin_ID
dc.titlePengaruh Ekstrak Daun Sirsak (Annona Muricata Linn.) Terhadap Aktivitas Inhibisienzim Asetilkolinesterasein_ID
dc.typeArticlein_ID


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record